Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 8.50
+0.40 (4.94%)
At close: Dec 5, 2025
Vytrus Biotech Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 8.09 | 6.09 | 4.7 | 4.48 | 3.51 | 2.23 | Upgrade
|
| Revenue Growth (YoY) | 54.38% | 29.51% | 4.90% | 27.57% | 57.47% | 25.74% | Upgrade
|
| Cost of Revenue | 0.77 | 0.59 | 0.35 | 0.35 | 0.26 | 0.11 | Upgrade
|
| Gross Profit | 7.32 | 5.5 | 4.35 | 4.13 | 3.25 | 2.12 | Upgrade
|
| Selling, General & Admin | 3.98 | 3.76 | 3.29 | 2.86 | 2.29 | 1.57 | Upgrade
|
| Other Operating Expenses | 0.33 | -0.08 | -0.07 | -0.03 | -0.02 | -0.04 | Upgrade
|
| Operating Expenses | 5.22 | 4.51 | 3.94 | 3.52 | 2.84 | 1.92 | Upgrade
|
| Operating Income | 2.1 | 0.98 | 0.4 | 0.61 | 0.41 | 0.2 | Upgrade
|
| Interest Expense | -0.1 | -0.12 | -0.15 | -0.2 | -0.12 | -0.12 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.02 | 0.01 | 0.01 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0.01 | -0 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | - | Upgrade
|
| EBT Excluding Unusual Items | 2.05 | 0.91 | 0.29 | 0.44 | 0.31 | 0.08 | Upgrade
|
| Asset Writedown | - | - | - | - | -0 | -0.03 | Upgrade
|
| Other Unusual Items | -0.01 | -0.01 | 0.02 | 0.01 | 0 | -0 | Upgrade
|
| Pretax Income | 2.05 | 0.9 | 0.31 | 0.45 | 0.31 | 0.09 | Upgrade
|
| Income Tax Expense | 0.09 | -0.12 | -0.24 | -0.15 | -0.14 | -0.13 | Upgrade
|
| Net Income | 1.95 | 1.02 | 0.54 | 0.61 | 0.45 | 0.22 | Upgrade
|
| Net Income to Common | 1.95 | 1.02 | 0.54 | 0.61 | 0.45 | 0.22 | Upgrade
|
| Net Income Growth | 180.18% | 87.36% | -9.96% | 34.49% | 107.48% | - | Upgrade
|
| Shares Outstanding (Basic) | - | 8 | 7 | - | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | - | 8 | 7 | - | 7 | 7 | Upgrade
|
| Shares Change (YoY) | - | 11.71% | - | - | 0.43% | -0.92% | Upgrade
|
| EPS (Basic) | - | 0.14 | 0.08 | - | 0.06 | 0.03 | Upgrade
|
| EPS (Diluted) | - | 0.14 | 0.08 | - | 0.06 | 0.03 | Upgrade
|
| EPS Growth | - | 67.72% | - | - | 106.59% | - | Upgrade
|
| Free Cash Flow | 2.7 | 1.74 | 0.76 | 0.61 | 0.23 | -0.32 | Upgrade
|
| Free Cash Flow Per Share | - | 0.23 | 0.11 | - | 0.03 | -0.05 | Upgrade
|
| Gross Margin | 90.53% | 90.28% | 92.46% | 92.14% | 92.60% | 94.98% | Upgrade
|
| Operating Margin | 26.02% | 16.17% | 8.60% | 13.53% | 11.65% | 8.82% | Upgrade
|
| Profit Margin | 24.14% | 16.76% | 11.59% | 13.50% | 12.81% | 9.72% | Upgrade
|
| Free Cash Flow Margin | 33.40% | 28.62% | 16.22% | 13.51% | 6.47% | -14.15% | Upgrade
|
| EBITDA | 2.37 | 1.18 | 0.6 | 0.75 | 0.99 | 0.59 | Upgrade
|
| EBITDA Margin | 29.32% | 19.33% | 12.67% | 16.82% | 28.06% | 26.51% | Upgrade
|
| D&A For EBITDA | 0.27 | 0.19 | 0.19 | 0.15 | 0.58 | 0.39 | Upgrade
|
| EBIT | 2.1 | 0.98 | 0.4 | 0.61 | 0.41 | 0.2 | Upgrade
|
| EBIT Margin | 26.02% | 16.17% | 8.60% | 13.53% | 11.65% | 8.82% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.